About the Authors
- Hana Kammoun
-
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
- Xavier Roux
-
Current address: Tolerys Biolabs SAS, Bâtiment le Forum 2, Archamps Technopôle, Archamps, France
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
- Dominique Raze
-
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
- Anne-Sophie Debrie
-
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
- Marina De Filette
-
Current address: Laboratory of Gene Therapy, Faculty of Veterinary Sciences, Ghent University, Merelbeke, Belgium
Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
- Tine Ysenbaert
-
Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
- Nathalie Mielcarek
-
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
- Xavier Saelens
-
Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
- Walter Fiers
-
Affiliations Department for Molecular Biomedical Research, VIB, Ghent, Belgium, Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
- Camille Locht
-
* E-mail: camille.locht@pasteur-lille.fr
Affiliations Inserm U1019, Lille, France, CNRS UMR 8204, Lille, France, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France, University Lille Nord de France, Lille, France
Competing Interests
The authors have read the journal’s policy and have the following conflicts. Several patents have been applied on the recombinant attenuated B. pertussis strains, as well as on M2e as a potential vaccine antigen. These patent rights are owned by the institutions to which the authors are affiliated. Although a small part of the work (M2e-VLP construction) was done in collaboration with SanofiPasteur, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: XS WF CL. Performed the experiments: HK XR DR ASD MDF TY. Analyzed the data: HK NM XS WF CL. Wrote the paper: HK XS CL.